0 CTCAE Publish Date May 28, 2009 provide a grading scale for adverse events as follows <a href=http://nolvadex.best>nolvadex</a> Table 1 lists treatment emergent adverse reactions that were reported in three 12 week, placebo controlled monotherapy trials involving 1597 hypertensive patients treated with either 5 mg, 10 mg, or 20 40 mg of Nebivolol and 205 patients given placebo and for which the rate of occurrence was at least 1 of patients treated with nebivolol and greater than the rate for those treated with placebo in at least one dose group